| Charles Joseph Paradelas, RPH | |
|
7411 Florida Blvd, Baton Rouge, LA 70806-4639 | |
| (225) 928-8982 | |
| (225) 928-8986 |
| Full Name | Charles Joseph Paradelas |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 7411 Florida Blvd, Baton Rouge, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013265115 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 11248 (Louisiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Charles Joseph Paradelas, RPH 7411 Florida Blvd, Baton Rouge, LA 70806-4639 Ph: (225) 928-8982 | Charles Joseph Paradelas, RPH 7411 Florida Blvd, Baton Rouge, LA 70806-4639 Ph: (225) 928-8982 |
News Archive
Acromio-clavicular joint dislocation is one of the most common shoulder injuries orthopedic surgeons treat. Severe dislocations are often treated with surgery, but patients who opt for non-surgical treatment typically experience fewer complications and return to work sooner, according to new research published today in the Journal of Orthopaedic Trauma.
New research has shown human neural stem cells could improve blood flow in critical limb ischemia through the growth of new vessels. Critical limb ischemia is a disease that severely obstructs arteries and reduces the blood flow to legs and feet. CLI remains an unmet clinical problem and with an ageing population and the rise in type II diabetes, the incidence of CLI is expected to increase.
Deafness in early childhood is known to lead to lasting changes in how sounds are processed in the brain, but new research published today in eLife shows that even mild-to-moderate levels of hearing loss in young children can lead to similar changes.
Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) today announced data presented at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) showing the potential of TYSABRI® (natalizumab) to redefine successful multiple sclerosis (MS) therapy.
› Verified 7 days ago
Mr. Kenneth W. Howie, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7515 Perkins Rd, Baton Rouge, LA 70808 Phone: 225-769-6084 Fax: 225-767-7300 | |
Mrs. Sharon Ann Alcorn, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4485 Perkins Rd, Baton Rouge, LA 70808 Phone: 225-926-0734 | |
Sonya Bremer Boss, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3239 Riverwalk Dr, Baton Rouge, LA 70820 Phone: 225-281-1475 Fax: 225-578-7163 | |
Norman Francise, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10974 Joor Rd, Baton Rouge, LA 70818 Phone: 225-261-4530 | |
Paul Antoine Bordelon, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6920 Plank Rd, Baton Rouge, LA 70811 Phone: 225-356-0654 | |
Ms. Jennifer Leane Simpson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10974 Joor Rd, Baton Rouge, LA 70818 Phone: 225-261-4530 Fax: 225-261-1622 |